ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China · Delayed Price · Currency is CNY

40.87

-1.81 (-4.24%)

Mar 19, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Specialty Chemicals	333.13M	414.30M	411.46M	415.73M	373.04M
Specialty Chemicals Growth	-19.59%	0.69%	-1.03%	11.44%	26.89%
Total	333.13M	414.30M	411.46M	415.73M	373.04M
Total Growth	-19.59%	0.69%	-1.03%	11.44%	26.89%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	223.50M	264.94M	205.85M	194.96M	244.93M
China Growth	-15.64%	28.70%	5.59%	-20.40%	-
Foreign	109.63M	149.37M	205.61M	220.76M	128.04M
Foreign Growth	-26.60%	-27.35%	-6.86%	72.42%	-
Total	333.13M	414.30M	411.46M	415.73M	372.96M
Total Growth	-19.59%	0.69%	-1.03%	11.47%	-

Source: S&P Global Market Intelligence.